Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Transalta (TSLTF) EBT (2016 - 2025)

Historic EBT for Transalta (TSLTF) over the last 17 years, with Q3 2025 value amounting to -$38.5 million.

  • Transalta's EBT fell 68358.81% to -$38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$135.5 million, marking a year-over-year decrease of 15682.17%. This contributed to the annual value of $233.0 million for FY2024, which is 6427.66% down from last year.
  • Transalta's EBT amounted to -$38.5 million in Q3 2025, which was down 68358.81% from -$95.0 million recorded in Q2 2025.
  • Transalta's 5-year EBT high stood at $337.9 million for Q3 2023, and its period low was -$350.3 million during Q3 2021.
  • Its 5-year average for EBT is $42.6 million, with a median of $16.6 million in 2021.
  • Its EBT has fluctuated over the past 5 years, first surged by 135852.7% in 2022, then tumbled by 77869.96% in 2023.
  • Quarter analysis of 5 years shows Transalta's EBT stood at -$25.4 million in 2021, then skyrocketed by 120.31% to $5.2 million in 2022, then crashed by 778.7% to -$35.0 million in 2023, then crashed by 45.71% to -$51.0 million in 2024, then increased by 24.51% to -$38.5 million in 2025.
  • Its EBT stands at -$38.5 million for Q3 2025, versus -$95.0 million for Q2 2025 and $49.0 million for Q1 2025.